Modern antiepileptic drugs: guidelines and beyond

Current Opinion in Neurology
Nikolas Hitiris, Martin J Brodie

Abstract

Ten antiepileptic drugs have been licensed since 1990. Their usage will be briefly reviewed focusing on new data and inclusion in guidelines. The hypotheses exploring the underlying basis of pharmacoresistance will be presented. Lamotrigine, gabapentin, topiramate, and oxcarbazepine are available for use as monotherapy in many countries following comparative studies with older antiepileptic drugs. Zonisamide and pregabalin have recently obtained licences as adjuvant therapy in the US and Europe for partial epilepsy with or without secondary generalization. The UK National Institute for Clinical Excellence guideline has advised, largely based on cost, against the routine use of modern antiepileptic drugs, except when older drugs have failed or are contraindicated. This contrasts with the US guidelines which are less conservative. Surgically resected specimens from patients with refractory epilepsy have led to the development of two hypotheses to explain pharmacoresistant epilepsy. The introduction of 10 new antiepileptic drugs has provided greater choice for patients and doctors, although evidence in support of their superiority over the older drugs is sparse. This has led to conflicting advice in guidelines. Recent developments...Continue Reading

References

Jan 18, 1996·The New England Journal of Medicine·M J Brodie, M A Dichter
Feb 26, 1998·Epilepsy Research·M Kyllerman, E Ben-Menachem
May 13, 1998·Epilepsia·J M Pellock, M J Brodie
May 21, 1998·Clinical Pharmacokinetics·R C Sachdeo
Feb 5, 2000·The New England Journal of Medicine·P Kwan, M J Brodie
Feb 11, 2000·Seizure : the Journal of the British Epilepsy Association·T MiyamotoT Koyama
Sep 7, 2000·Current Opinion in Oncology·B TanL Ratner
Feb 13, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·A G Marson, D W Chadwick
Oct 24, 2001·Epilepsy Research·S Arroyo, A de la Morena
Nov 28, 2001·Neurology·E FaughtUNKNOWN Zonisamide 922 Trial Group
Dec 12, 2001·Neurología : publicación oficial de la Sociedad Española de Neurología·S Arroyo
Apr 12, 2002·Epilepsy Research·Giangennaro CoppolaAntonio Pascotto
Apr 16, 2002·Epilepsia·Philip N PatsalosClementina M van Rijn
Aug 30, 2002·Epilepsia·Martin J BrodieUNKNOWN Gabapentin Study Group 945-212
Feb 4, 2003·Expert Opinion on Pharmacotherapy·Hyunmi Choi, Martha J Morrell
Apr 1, 2003·Annals of Neurology·Stefan RemyHeinz Beck
Apr 25, 2003·Cancer Control : Journal of the Moffitt Cancer Center·Hilary Thomas, Helen M Coley
Aug 5, 2003·Paediatric Drugs·Lynne Bang, Karen Goa
Aug 27, 2003·Neurology·Anne SabersTorbjörn Tomson
Sep 12, 2003·Seizure : the Journal of the British Epilepsy Association·Rajiv Mohanraj, Martin J Brodie
Sep 25, 2003·Journal of Neuropathology and Experimental Neurology·Susanne PirkerGünther Sperk
Oct 10, 2003·CNS Drugs·John Waugh, Karen L Goa
Nov 25, 2003·Seizure : the Journal of the British Epilepsy Association·Gregory L KraussAkemi Miller
Dec 25, 2003·Epilepsia·Linda J Stephen, Martin J Brodie
Dec 25, 2003·Epilepsia·Santiago ArroyoUNKNOWN Pregabalin 1008-011 International Study Group
Dec 25, 2003·Neurology·J McDonaghM J Brodie

❮ Previous
Next ❯

Citations

May 15, 2012·Epilepsy & Behavior : E&B·Doris D WangWilliam L Young
Feb 8, 2011·La Presse médicale·Vincent Navarro
Dec 23, 2009·Brain Research Reviews·Marco WeiergräberRüdiger Köhling
Jan 7, 2009·Epilepsy Research·Nora MatarMarco Weiergräber
Mar 27, 2007·La Presse médicale·Vincent Navarro
Jan 14, 2009·Seizure : the Journal of the British Epilepsy Association·Helena GauffinBirgitta Söderfeldt
Apr 11, 2007·Seizure : the Journal of the British Epilepsy Association·Cecilie Johannessen LandmarkSvein I Johannessen
May 7, 2010·The Journal of Pharmacology and Experimental Therapeutics·Gregor BenderMeindert Danhof
Aug 2, 2019·International Journal of Molecular Sciences·Giuseppina Daniela NaimoSebastiano Cavallaro
Jul 22, 2017·Frontiers in Neurology·Fei TangBjörn Bauer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.